Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Fall;3(4):279-86.

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

Anahita Nosrati  1 , Farshad Naghshvar  1 , Somaieh Khanari  1
Affiliations

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

Anahita Nosrati et al. Int J Mol Cell Med. 2014 Fall.

Abstract

Cancer stem cells (CSCs) are unique subpopulations that have the capacity to drive malignant progression with renewal abilities. Recently the role of some of CSCs in gastric adenocarcinoma has been studied. This study was performed in order to evaluate CD44 and CD133 expressions by immunohistochemistry in 95 primary gastric adenocarcinoma and their relation to clinical and pathological parameters of these tumors. There was a significant correlation between CD44 expression and cancer subtype (intestinal), tumor size (4-8 cm), depth of invasion, no lymphatic/vascular invasion and moderate differentiation. There was a significant correlation between CD133 expression and patient's age (> 65 years), cancer subtype (intestinal), tumor size (4-8 cm), depth of invasion and moderate differentiation. CSC markers like CD 44 and CD133 had high expression in primary gastric adenocarcinoma and had some relations to clinical and pathological parameters of tumors.

Keywords: CD133; CD44; Primary gastric adenocarcinoma; cancer stem cell; immunohistochemistry.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Immunohistochemical staining of gastric adenocarcinoma. CD44 negative control (A), CD133 negative control (B), CD44 and CD133 expressions in cytoplasm of tumor cells (C and D respectively). IHC (400 x)
See this image and copyright information in PMC

References

    1. Zhao P, Li Y, Lu Y. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer. 2010;10:218–24. - PMC - PubMed
    1. Rocco A, Compare D, Nardone G. Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions. World J Gastrointest Oncol. 2012;4:54–9. - PMC - PubMed
    1. Taghavi N, Nasrollahzadeh D, Merat S, et al. Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases. World J Gastroenterol. 2007;13:5367–70. - PMC - PubMed
    1. center for disease control; 2005. [Accessed August 26, 2003]. Center for disease control, Deputy of health, Iranian ministry of health and medical education , national report of cancer registry. Available at: http://www.hon.ch / HONcode / Conduct. html.
    1. Mohebbi M, Mahmoodi M, Wolfe R, et al. Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer. 2008;8:137. - PMC - PubMed

LinkOut - more resources